Menu
Back to User profile » Dr Xuefei Li
Papers published by Dr Xuefei Li:
Single-Cell Profiling of Tumor-Associated Neutrophils in Advanced Non-Small Cell Lung Cancer
Shi J, Li J, Wang H, Li X, Wang Q, Zhao C, Cheng L, Han R, Chen P, Guo H, Tang Z, Zhou C, Zhang Z, Wu F
Lung Cancer: Targets and Therapy 2023, 14:85-99
Published Date: 21 November 2023
Adenocarcinoma of High-Grade Patterns Associated with Distinct Outcome of First-Line Chemotherapy or EGFR-TKIs in Patients of Relapsed Lung Cancer
Yu X, Dong Z, Wang W, Mao S, Pan Y, Liu Y, Yang S, Chen B, Wang C, Li X, Zhao C, Jia K, Shao C, Wu C, Ren S, Zhou C
Cancer Management and Research 2021, 13:3981-3990
Published Date: 17 May 2021
PD-1/PD-L1 Inhibitor Combined with Chemotherapy Can Improve the Survival of Non-Small Cell Lung Cancer Patients with Brain Metastases
Sun C, Zhou F, Li X, Zhao C, Li W, Li J, Xiong A, Yu J, Gao G, Wang Q, Wu F, Zhou C
OncoTargets and Therapy 2020, 13:12777-12786
Published Date: 14 December 2020
High feasibility of cytological specimens for detection of ROS1 fusion by reverse transcriptase PCR in Chinese patients with advanced non-small-cell lung cancer
Zhang L, Wang Y, Zhao C, Shi J, Zhao S, Liu X, Jia Y, Zhu T, Jiang T, Li X, Zhou C
OncoTargets and Therapy 2019, 12:3305-3311
Published Date: 1 May 2019
TIM-3, a promising target for cancer immunotherapy
He Y, Cao J, Zhao C, Li X, Zhou C, Hirsch FR
OncoTargets and Therapy 2018, 11:7005-7009
Published Date: 16 October 2018
Seven-microRNA panel for lung adenocarcinoma early diagnosis in patients presenting with ground-glass nodules
He Y, Yang Y, Kuang P, Ren S, Rozeboom L, Rivard CJ, Li X, Zhou C, Hirsch FR
OncoTargets and Therapy 2017, 10:5915-5926
Published Date: 13 December 2017
Comparison of erlotinib and pemetrexed as second-/third-line treatment for lung adenocarcinoma patients with asymptomatic brain metastases
He YY, Sun WW, Wang Y, Ren SX, Li XF, Li JY, Rivard CJ, Zhou CC, Hirsch FR
OncoTargets and Therapy 2016, 9:2409-2414
Published Date: 21 April 2016